PlainRecalls
FDA Drug Moderate Class II Ongoing

Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.

Reported: August 7, 2024 Initiated: July 23, 2024 #D-0623-2024

Product Description

Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.

Reason for Recall

Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.

Details

Recalling Firm
FDC Limited
Units Affected
66,528 bottles
Distribution
U.S. A. Nationwide
Location
Aurangabad, Maharashtra State, N/A

Frequently Asked Questions

What product was recalled?
Ciprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5 mL (NDC 69315-308-02), Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India.. Recalled by FDC Limited. Units affected: 66,528 bottles.
Why was this product recalled?
Defective container: unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 7, 2024. Severity: Moderate. Recall number: D-0623-2024.